Rep. Josh Gottheimer bought Insmed (INSM)
Rep. Josh Gottheimer (D-NJ-5) · $1K–$15K · traded Jun 16, 2025
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Joint
- Traded
- Jun 16, 2025
- Disclosed
- Jul 16, 2025
- Days to disclose
- 30
- Asset type
- Stock
- As filed
- Insmed Incorporated - Common Stock
- Industry
- Biotechnology · Healthcare
Other trades in this filing
- Jul 16, 2025$1K–$15K
$1K–$15K · Traded Jun 26, 2025 · disclosed Jul 16, 2025 · Joint
Committee overlap: Financial ServicesGot $13K from the company’s PAC - Jul 16, 2025$1K–$15K
$1K–$15K · Traded Jun 25, 2025 · disclosed Jul 16, 2025 · Joint
Committee overlap: Financial ServicesGot $13K from the company’s PAC - Jul 16, 2025$1K–$15K
$1K–$15K · Traded Jun 25, 2025 · disclosed Jul 16, 2025 · Joint
- Jul 16, 2025$1K–$15K
$1K–$15K · Traded Jun 24, 2025 · disclosed Jul 16, 2025 · Joint
- Jul 16, 2025$1K–$15K
Sold (partial) ConocoPhillips COP
$1K–$15K · Traded Jun 24, 2025 · disclosed Jul 16, 2025 · Joint
- Jul 16, 2025$1K–$15K
$1K–$15K · Traded Jun 24, 2025 · disclosed Jul 16, 2025 · Joint
Committee overlap: Financial ServicesGot $13K from the company’s PAC - Jul 16, 2025$1K–$15K
$1K–$15K · Traded Jun 20, 2025 · disclosed Jul 16, 2025 · Joint
- Jul 16, 2025$1K–$15K
$1K–$15K · Traded Jun 20, 2025 · disclosed Jul 16, 2025 · Joint
Committee overlap: Financial ServicesGot $13K from the company’s PAC - Jul 16, 2025$1K–$15K
$1K–$15K · Traded Jun 20, 2025 · disclosed Jul 16, 2025 · Joint
- Jul 16, 2025$1K–$15K
$1K–$15K · Traded Jun 20, 2025 · disclosed Jul 16, 2025 · Joint
Got $5K from the company’s PAC - Jul 16, 2025$1K–$15K
$1K–$15K · Traded Jun 13, 2025 · disclosed Jul 16, 2025 · Joint
Committee overlap: Financial Services - Jul 16, 2025$1K–$15K
$1K–$15K · Traded Jun 5, 2025 · disclosed Jul 16, 2025 · Joint
- Jul 16, 2025$1K–$15K
$1K–$15K · Traded Jun 4, 2025 · disclosed Jul 16, 2025 · Joint
- Jul 16, 2025$1K–$15K
$1K–$15K · Traded Jun 4, 2025 · disclosed Jul 16, 2025 · Joint
- Jul 16, 2025$1K–$15K
Sold Fidelity National Information Services FIS
$1K–$15K · Traded Jun 3, 2025 · disclosed Jul 16, 2025 · Joint
- Jul 16, 2025$1K–$15K
$1K–$15K · Traded Jun 3, 2025 · disclosed Jul 16, 2025 · Joint
- Jul 16, 2025$1K–$15K
$1K–$15K · Traded Jun 3, 2025 · disclosed Jul 16, 2025 · Joint
Got $5K from the company’s PAC
Recent Congress trades in INSM
- Jul 7, 2026$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Jun 10, 2026 · disclosed Jul 7, 2026 · Joint
- Nov 18, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Oct 3, 2025 · disclosed Nov 18, 2025 · filed 46 days later
- Oct 10, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Sep 22, 2025 · disclosed Oct 10, 2025
- Sep 12, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Aug 8, 2025 · disclosed Sep 12, 2025
- Aug 14, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Jul 7, 2025 · disclosed Aug 14, 2025
- May 14, 2025$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Apr 9, 2025 · disclosed May 14, 2025 · Joint
- Jul 9, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Jun 21, 2024 · disclosed Jul 9, 2024 · Joint
- Jun 8, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded May 28, 2024 · disclosed Jun 8, 2024 · Joint
Company context for INSM
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
INSM: third_quarter 2026 lobbying report
MFN Issues.
Public: Oct 19, 2026, 7:29 AM EDTOriginal source ↗INSM: third_quarter 2026 lobbying report
General Issues of interest to pharmaceutical companies Issues related to Medicare reimbursement of pharmaceutical products
Public: Oct 18, 2026, 6:49 PM EDTOriginal source ↗INSM: second_quarter 2026 lobbying report
General Issues of interest to pharmaceutical companies Issues related to Medicare reimbursement of pharmaceutical products
Public: Jul 20, 2026, 3:07 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.